<sup>18</sup>F-FDG PET/CT and <sup>68</sup>Ga-DOTATATE PET/CT Findings of Polycystic Kidney-derived Paraganglioma
PDF
Cite
Share
Request
Interesting Image
P: 182-184
October 2024

18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings of Polycystic Kidney-derived Paraganglioma

Mol Imaging Radionucl Ther 2024;33(3):182-184
1. University of Health Sciences Türkiye İstanbul Training and Research Hospital, Clinic of Nuclear Medicine, İstanbul, Türkiye
2. University of Health Sciences Türkiye İstanbul Training and Research Hospital, Clinic of Pathology, İstanbul, Türkiye
No information available.
No information available
Received Date: 04.08.2023
Accepted Date: 28.01.2024
Online Date: 07.10.2024
Publish Date: 07.10.2024
PDF
Cite
Share
Request

ABSTRACT

Paragangliomas (PGLs) are neuroendocrine tumors originating from the neural crest. They usually arise from the adrenal medulla and sympathetic or parasympathetic ganglions. Approximately 10% of PGLs are located in the extra-adrenal gland. Renal PGL is a rare condition. In this case report, we present the 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and 68Ga-DOTATATE PET/CT findings of polycystic kidney-derived PGL.

References

1
Neumann HPH, Young WF Jr, Eng C. Pheochromocytoma and Paraganglioma. N Engl J Med. 2019;381:552-565.
2
Bahar B, Pambuccian SE, Gupta GN, Barkan GA. Renal paraganglioma: report of a case managed by robotic assisted laparoscopic partial nephrectomy and review of the literature. Case Rep Urol. 2014;2014:527592.
3
Peng C, Bu S, Xiong S, Wang K, Li H. Non-functioning paraganglioma occurring in the urinary bladder: A case report and review of the literature. Oncol Lett. 2015;10:321-324.
4
Yi C, Han L, Yang R, Yu J. Paraganglioma of the renal pelvis: a case report and review of literature. Tumori. 2017;103(Suppl 1):e47-e49.
5
Taïeb D, Timmers HJ, Hindié E, Guillet BA, Neumann HP, Walz MK, Opocher G, de Herder WW, Boedeker CC, de Krijger RR, Chiti A, Al-Nahhas A, Pacak K, Rubello D; European Association of Nuclear Medicine. EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2012;39:1977-1995.
6
Sobocki BK, Perdyan A, Szot O, Rutkowski J. Management of Pheochromocytomas and Paragangliomas: A Case-Based Review of Clinical Aspects and Perspectives. J Clin Med. 2022;11:2591.
7
Şahin R, Baykal Koca S, Yücetaş U, Çermik TF, Ergül N. 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings in a Patient With Primary Renal Well-Differentiated Neuroendocrine Tumor. Clin Nucl Med. 2022;47:e503-e505.
8
Skoura E, Priftakis D, Novruzov F, Caplin ME, Gnanasegaran G, Navalkissoor S, Bomanji J. The impact of Ga-68 DOTATATE PET/CT imaging on management of patients with paragangliomas. Nucl Med Commun. 2020;41:169-174.
9
Chang CA, Pattison DA, Tothill RW, Kong G, Akhurst TJ, Hicks RJ, Hofman MS. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity. Cancer Imaging. 2016;16:22.
10
Carrasquillo JA, Chen CC, Jha A, Ling A, Lin FI, Pryma DA, Pacak K. Imaging of Pheochromocytoma and Paraganglioma. J Nucl Med. 2021;62:1033-1042.